Impact of Medicaid Expansion on Survival in Colorectal Cancer with Liver Metastasis: A Population-Based Analysis

Highlight

  • Medicaid expansion (ME) under the Affordable Care Act is linked with a significant reduction in 3-year disease-specific mortality among patients under 65 years diagnosed with colorectal cancer and synchronous liver metastasis (CRLM).
  • The mortality benefit was most pronounced in patients undergoing liver metastasectomy, suggesting improved access to complex multidisciplinary surgical and systemic oncologic care.
  • Decreased mortality was observed starting 2-3 years after Medicaid expansion and persisted beyond 6 years, despite no significant increase in liver surgery rates.
  • ME may enhance continuity and quality of complex cancer care by facilitating access to systemic therapies and multidisciplinary management in populations historically underserved.

Specialty calculators

Browse calculators

For clinical reference; use professional judgment.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply